Determining how effectively a drug is being absorbed by the human body is a tricky business.
While age and weight can give doctors a good indication, a patients’ metabolism, the foods they eat and other drugs they might be taking can all have an effect on efficacy.
Looking to solve this problem, engineers from the University of California, Santa Barbara have developed an implantable device that provides real time feedback on how much medication is currently in a person’s bloodstream.
While still in the early stages of development, the researchers say the prototype device, called MEDIC (Microfluidic Electrochemical Detector for In vivo Concentrations), could revolutionise the way treatment is given and measured in the future.
Kevin Plaxco, a professor of biomolecular science and engineering, believes it could even be used to deliver drugs automatically, with dosages based on the feedback generated by the device.
An artificial pancreas, which monitors glucose levels in diabetics and uses this information to inject a controlled amount of insulin, is an example of one such system.
The MEDIC device consists of a microfluidic chamber lined with gold electrodes from which drug-recognising biomolecules – in this case artificial DNA strands called aptamers – extend.
When the target molecule comes in contact with an aptamer, the strand recognises it and wraps around the molecule, delivering electrons from its tip to the electrode at the aptamer’s base. The tiny jolt of current signals the presence of the molecule.
Because previous iterations of the device failed within half an hour – due to the components in whole blood clinging to the sensors – the researchers decided to introduce a second flow into the chamber.
This acted like a filter, separating the large blood components from the small drug molecules.
In tests, the researchers found they could easily and accurately measure the effectiveness of a particular drug in the bloodstream, even when a cocktail of drugs was administered.
The Latest on: Drug levels in the bloodstream
via Google News
The Latest on: Drug levels in the bloodstream
- The Alzheimer's Drugs Showing Early Promiseon January 22, 2021 at 3:08 pm
A small study has found that the experimental drug donanemab may slow cognitive decline in Alzheimer's patients. It joins others that show promise.
- Blood Cancer Drugs Market Size 2020 Analysis and In-depth Research on Trends, Emerging Growth Factors and Forecast to 2024on January 22, 2021 at 5:59 am
Jan (The Expresswire) -- "Final Report will add the analysis of the impact of COVID-19 on this industry." Blood cancers, or hematologic ...
- New trial finds arthritis drug no better than standard care for severe COVID-19on January 21, 2021 at 3:50 pm
Adding the arthritis drug tocilizumab to standard care for patients in hospital with severe or critical covid-19 is no better than standard care alone in improving clinical outcomes at 15 days, ...
- Arthritis Drug Tocilizumab Flops as COVID-19 Treatmenton January 21, 2021 at 7:09 am
The arthritis drug tocilizumab doesn't help hospital patients with severe COVID-19, according to a new study that contradicts earlier research suggesting that it might aid recovery. In fact, patients ...
- Nanotech Jumps Blood-Brain Barrier To Kill Cancer in Miceon January 21, 2021 at 1:13 am
A new synthetic protein nanoparticle capable of slipping past the nearly impermeable blood-brain barrier in mice could deliver cancer-killing drugs directly to malignant brain tumors, new research ...
- COVID SCIENCE-S. African virus variant may resist antibody drugs; Pfizer/BioNTech vaccine seems to work vs UK varianton January 20, 2021 at 5:05 pm
The following is a roundup of some of the latest scientific studies on the novel coronavirus and efforts to find treatments and vaccines for COVID-19, the illness caused by the virus.
- New trial finds arthritis drug tocilizumab no better than standard care for severe COVID-19on January 20, 2021 at 3:41 pm
Adding the arthritis drug tocilizumab to standard care for patients in hospital with severe or critical COVID-19 is no better than standard care alone in improving clinical outcomes at 15 days, finds ...
- New Safety Concern for Migraine Drug?on January 20, 2021 at 3:32 pm
Erenumab, the first in a relatively new class of drugs approved for migraine prevention, is a monoclonal antibody designed to block the calcitonin gene-related peptide (CGRP) receptor. CGRP is a ...
- Ceracare Supplement Reviews – CeraCare Advanced Blood Sugar Support Facts Revealed by Liver Philon January 20, 2021 at 2:32 pm
Brand Partner Content by KISS PR Brand Story* High blood sugar and diabetes are menaces that are threatening millions of people worldwide. About 1.6 million deaths are attributed to diabetes every ...
- Two common blood pressure drugs are not tied to increased risk of COVID-19on January 18, 2021 at 3:51 pm
Research published in the peer-reviewed journal The Lancet Digital Health and co-led by a UCLA Fielding School of Public Health faculty member has found that two widely used types of blood pressure ...
via Bing News